Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc., is based in NEW YORK.
| Revenue (Most Recent Fiscal Year) | $1.00M |
| Net Income (Most Recent Fiscal Year) | $-16.01M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | -- |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.05 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -59891.80% |
| Net Margin (Trailing 12 Months) | -- |
| Return on Equity (Trailing 12 Months) | -212.19% |
| Return on Assets (Trailing 12 Months) | -199.12% |
| Current Ratio (Most Recent Fiscal Quarter) | 31.62 |
| Quick Ratio (Most Recent Fiscal Quarter) | 31.62 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | -- |
| Book Value per Share (Most Recent Fiscal Quarter) | $1.52 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-7.43 |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | -- |
| Exchange | NASDAQ |
| Sector | Financial Services |
| Industry | Capital Markets |
| Common Shares Outstanding | 123.97M |
| Free Float | 113.46M |
| Market Capitalization | $603.72M |
| Average Volume (Last 20 Days) | 3.14M |
| Beta (Past 60 Months) | 1.58 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 8.48% |
| Percentage Held By Institutions (Latest 13F Reports) | 9.45% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |